A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Lacto-N-difucohexaose II | Lacto-N-difucohexaose II, a carbohydrate compound prevalent in the biomedical industry for research purposes, has been found to impede pathogen adhesion to human intestinal cells. This realization has spurred speculation on the potential of Lacto-N-difucohexaose II as a viable candidate in the development of drug interventions for infectious maladies afflicting the gut. Equally exciting, Lacto-N-difucohexaose II may also offer promise as a cancer treatment. Synonyms: LNDFH II; Lewis A hexaose; D-Glucose, O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-(O-6-deoxy-alpha-L-galactopyranosyl-(1-4)-O-(beta-D-galactopyranosyl-(1-3))-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-beta-D-galactopyranosyl-(1-4))-; β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc. Grades: ≥95%. CAS No. 62258-12-2. Molecular formula: C38H65NO29. Mole weight: 999.91. |  |
| Lacto-N-difucohexaose IV | Lacto-N-difucohexaose IV, recognized as a pivotal compound constituent, presents itself as a prospective remedial aide for an array of ailments like bacterial and viral infections. By focusing on distinct receptors and impeding the proliferation of malevolent microorganisms, this indispensable compound extensively contributes to the research of pathogenic infections. Its exceptional efficacy renders it an invaluable compound for biomedical drug advancement. Synonyms: LNDFH IV. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucopentaose I | Cas No. 221224-60-8. | |
| Lacto-N-fucopentaose-1 | Fuca1®2Galb1®3GlcNAcb1®3Galb1®3Glc. Product ID: 3-00425. Molecular formula: C32H55NO25. Mole weight: 853.7. Reference: Anal. Biochem., 133, 1, 1983. |  |
| Lacto-N-fucopentaose-2 | Lewisa antigen. CAS No. 21973-23-9. Product ID: 3-02366. Molecular formula: C32H55NO25. Mole weight: 853.7. | |
| Lacto-N-fucopentaose-3 | Lewisx antigen. Product ID: 3-02367. Molecular formula: C32H55NO25. Mole weight: 853.7. | |
| Lacto-N-fucopentaose I | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and Apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development. Synonyms: LNFP I; Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; Blood group O(H) type I determinant; α-l-fuc(1?2)-β-d-gal-(1?3)-β-d-glcnac-(1?3)-β-d-gal-(1?4)-d-glc; 6-Desoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)-2-acetamido-2-desoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose. Grades: ≥95%. CAS No. 7578-25-8. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose I-biotin | Lacto-N-fucopentaose I-biotin - a bio-reagent in the biomedical industry. It helps researchers detect and analyze fucosylated oligosaccharides. Its biotin modification provides tactical binding options, leading to a better understanding of fucosylation events in biological processes such as pathogen binding, cancer development, and more. Molecular formula: C48H82N6O27S. Mole weight: 1207.26. | |
| Lacto-N-fucopentaose I-BSA | | |
| Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) | Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) is an instrumental biomedical tool employed to unravel the intricate molecular interplay between proteins and carbohydrates. This glycoprotein conjugate harbors the enigmatic Lacto-N-fucopentaose I, a sui generis complex carbohydrate that adorns cell surfaces and resides in body fluids. The product's salience lies in its ability to diagnose and treat a plethora of ailments including cancers, infections, and inflammation. | |
| Lacto-N-fucopentaose II | It is a human milk oilgosaccharide that can be associated with some gastrointestinal tumors. Synonyms: LNFP II; Lewisa antigen; Lewis A antigen; b-D-Gal-(1?3)-(a-L-Fuc-[1?4])-b-D-GlcNAc-(1?3)-b-D-Gal-(1?4)-D-Glc; β-D-Galp-(1?3)-[α-L-Fucp-(1?4)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; Lewis-a pentasaccharide; LNF II; Lacto-N-fucopentaose-2; Lea penta. Grades: ≥95%. CAS No. 21973-23-9. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose II | Lacto-N-fucopentaose II (LNFP II) is a sialyl-Lewis, hapten of human Lewis bloodgroup determinant. Lacto-N-fucopentaose II monosialo-ganglioside/glycolipid and sialyl derivative, CA 19-9, is a molecular tumour markers (TM) for biliopancreatic malignancy [1]. Uses: Scientific research. Group: Natural products. Alternative Names: LNFP II. CAS No. 21973-23-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N7575. |  |
| Lacto-N-fucopentaose II-APD-HSA | | |
| Lacto-N-fucopentaose II-APD-KLH | Lacto-N-fucopentaose II-APD-KLH is an extraordinary bioactive compound prevalent in the biomedical sector, exhibitionizes immense promise for research across diverse diseases through its remarkable affinities for selective receptors, namely Fucosyltransferase and Galectins. It has garnered extensive utilization within research domains aiming to unravel the intricacies of cancer, inflammation and immune-related maladies, as well as devising innovative strategies for their effective research. | |
| Lacto-N-fucopentaose II-BSA | | |
| Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer) | Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer), a biomedicine product designed for unravelling the mysteries of glycan-protein interactions. Widely employed for diagnosis of Helicobacter pylori (H. pylori) in serum samples of infected individuals, its applications extend beyond the laboratory. Studies have revealed its crucial role in illuminating the intricacies of carbohydrate-mediated ailments such as cancer and inflammation. | |
| Lacto-N-fucopentaose II-GEL | Lacto-N-fucopentaose II-GEL is a paramount biomedical compound, serving as a tool for deciphering intricate complexities attributed to the functions and interplays of carbohydrates within cellular systems. By facilitating the detection of lectins, glycosylation analysis and exploration of carbohydrate impacts on disease advancement, this product assumes a pivotal significance. Its indispensability lies in unraveling the pathogenesis of specific ailments and forging prospects for prospective researchs. | |
| Lacto-N-fucopentaose III | It is a human milk oilgosaccharide that can inhibit the adherence of pathogens to the intestinal epithelium. Synonyms: LNFP III; Lewis X antigen; Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc; Lex-lactosel; Lewis-X pentasaccharide; β-D-Galp-(1?4)-[α-L-Fucp-(1?3)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-D-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-Glucopyranose; 6-Deoxy-α-L-galactopyranosyl-(1->3)-[β-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; Lacto-N-neofucopentaose II. Grades: ≥95%. CAS No. 25541-09-7. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose III-APD-HSA | | |
| Lacto-N-fucopentaose III-BSA | | |
| Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) | Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) is an astounding specialized biomedical wonder, harbors immense value for the scientific realm. This groundbreaking product unravels the intricacies behind carbohydrate-protein interactions, facilitating a comprehensive understanding of this enigmatic domain. A conjugate brimming with potential, LNFP III-BSA amalgamates the captivating carbohydrate structure of Lacto-N-fucopentaose III with the mighty Bovine Serum Albumin (BSA) and an elegant 3 atom spacer. Its importance transcends mere investigation, offering invaluable insights into drug development and the intricate pathology of diseases intricately linked to carbohydrate recognition. Prepare to embark on an academic odyssey like no other, courtesy of LNFP III-BSA. | |
| Lacto-N-fucopentaose III-GEL | Lacto-N-fucopentaose III-GEL is an advanced biomedical product engineered to precisely target and study diverse malignancies, including breast, ovarian and colon cancers. This exceptional gel conjugate seamlessly integrates the distinctive attributes of Lacto-N-fucopentaose III is a specific carbohydrate molecule, with a sophisticated gel matrix, thereby ensuring optimal drug administration and localized research. Through its selective adherence to cancerous cells, this compound holds remarkable prospects for individualized therapy, ultimately enhancing patient prognosis substantially. | |
| Lacto-N-fucopentaose V | Lacto-N-fucopentaose V, a groundbreaking biomedicine product, emerges as a pivotal therapeutic entity in the daunting battle against several diseases. Extensive scientific investigations have unraveled its potential prowess in cancer therapy by augmenting immune responses to combat malignant neoplasms. Moreover, its remarkable attributes offer hope in alleviating inflammatory bowel disease through the regulation of gut-associated inflammatory reactions. Synonyms: LNFPV; Galb1-3GlcNAcb1-3Galb1-4(Fuca1-3)Glc. CAS No. 60254-64-0. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose VI | Lacto-N-fucopentaose VI is an esteemed biomedical compound, standing tall as a prodigious therapeutic ally in studying multifarious ailments. Abounding in cascading units of fucose and lactosamine, this exquisite glycan has sparked rapt attention. Careful scrutiny has unveiled its prodigious potentialities in revolutionizing the domain of cancer inhibition, inflammation mitigation and bacterial afflictions. Delve deeper into its astounding architecture and intricate workings is as it emerges as a beacon of hope in the realms of targeted compound transportation and immunotherapeutic compounds. Synonyms: LNFP VI; D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-O-[6-deoxy-α-L-galactopyranosyl-(1?3)]-; Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-[Fuc-a1,3]Glc. Grades: 95%. CAS No. 145876-86-4. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-hexaose | core structure. Product ID: 3-02679. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lacto-N-hexaose | Lacto-N-hexaose is an esteemed and extensively employed compound with field assuming a pivotal position in the research of numerous afflictions such as gastrointestinal disorders and viral infections. By virtue of its distinctive structural composition, Lacto-N-hexaose showcases an unparalleled therapeutic capacity, thereby stimulating optimistic prospects for the creation of innovative pharmaceutical compounds intended to study these exigencies. Synonyms: LNH; LNThex; D-Glucose, O-beta-D-galactopyranosyl-(1-3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-O-(O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-6))-O-beta-D-galactopyranosyl-(1-4)-; β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-(β-D-Gal-[1?4]-β-D-GlcNAc-[1?6])-β-D-Gal-(1?4)-D-Glc. Grades: ≥95%. CAS No. 64003-51-6. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lactonic (di-acetylated) Sophorolipids | Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. Uses: Widely used in oilfield field, environmental remediation field, agriculture, animal husbandry and aquaculture fields, daily chemicals, cleaning, personal care: it can replace chemical surfactants, with excellent surface performance, safety, biodegradability, strong detergency, low foam type and easy to rinse. Synonyms: 17-L-[(2'-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-cis-9-octadecenoic acid 1',4"-lactone 6',6"-diacetate. CAS No. 148409-20-5. Molecular formula: C34H56O14. Mole weight: 688.80. | |
| Lactonic sophorolipid | Lactonic sophorolipid is an apoptosis inducer and antimicrobial surfactant with antitumor activity. Lactonic sophorolipid regulates Bax/Bcl-gene expression through caspase-3/9 and induces apoptosis in tumor cells. Lactonic sophorolipid can disrupt cell membrane permeability and exert antibacterial effects (MIC for oral pathogens is 100-400 ?g/mL). Lactonic sophorolipid promotes mitochondrial membrane potential depolarization, activates the intrinsic apoptotic pathway, and can synergize with antibiotics to enhance the antibacterial effect. Lactonic sophorolipid can be used in liver cancer research and the development of oral hygiene antibacterial agents[1][2][3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 148409-20-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-137371. | |
| Lactonic Sophorolipid | Lactonic Sophorolipid. Uses: Designed for use in research and industrial production. CAS No. 148409-20-5. Product ID: BBC148409205. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Lactonic Sophorolipid | Lactonic Sophorolipid. Synonyms: Lactonic (di-acetylated) Sophorolipids. CAS No. 148409-20-5. Pack Sizes: 25 kg. Product ID: CDC10-0372. Molecular formula: C34H56O14. Category: Cosmetic Surfactants. Product Keywords: Cosmetic Ingredients; Cosmetic Surfactants; Lactonic Sophorolipid; CDC10-0372; 148409-20-5; C34H56O14; Lactonic (di-acetylated) Sophorolipids; 148409-20-5. Purity: 0.5. Color: Light yellow to brown. Physical State: Liquid. Storage: Keep tightly closed. Avoid light and keep in cool and dry condition. Boiling Point: 843.8±65.0 °C(Predicted). Density: 1.152±0.06 g/cm3(Predicted). Product Description: Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. |  |
| Lacto-N-neodifucohexaose | Lacto-N-neodifucohexaose is a remarkable and prodigious compound, unveiling its colossal potentiality in an extensive array of ailments' therapies. Profoundly deviating from the conventional medicine panorama, this extraordinary compound manifests its profound therapeutic proficiencies through the prophylaxis of bacterial invasions is amplification of the immune system's prowess and alleviation of inflammation. Emanating as an epitome of immunomodulation, it has exhibited compelling outcomes when studying selected malignancies and gastrointestinal disorders. Furthermore, Lacto-N-neodifucohexaose serves as an invaluable diagnostic apparatus, proficiently identifying peculiar pathogens alongside distinct markers linked to sundry diseases. Synonyms: Gal-b-1-4(Fuc-a-1-3)GlcNAc-b-1-3Gal-b-1-4(Fuc-a-1-3)Glc; Lewis X hexaose; LNnDH. Molecular formula: C38H65NO29. Mole weight: 999.93. | |
| Lacto-N-neodifucohexaose II | Lacto-N-neodifucohexaose II is a highly esteemed compound in the biomedical sector, emerging as an invaluable resource boasting promising proclivities for studying specified ailments and circumstances. Delving into its potential therapeutic aptitudes concerning distinct pharmacological targets and disorders necessitates unwavering dedication towards empirical scientific investigations and meticulous clinical experimentation. Any inquisitive souls yearning for a comprehensive grasp of its multifaceted utilities and inherent characteristics are urged to peruse the instructive web portals duly mentioned for comprehensive elucidation. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-neofucopentaose | Lacto-N-neofucopentaose is a compound product used for investigating the role of carbohydrates in various diseases. This compound can be utilized for studying the binding properties and interactions with lectin proteins is aiding in the research of cancer, inflammation and microbial infections. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4(Fuc-a-1-3)Glc. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-neohexaose | Lacto-N-neohexaose is a cutting-edge compound with remarkable anti-inflammatory powers, aiding in the research of autoimmune disorders, most notably rheumatoid arthritis. Synonyms: D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-; O-β-D-Galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-D-glucose. Grades: ≥90%. CAS No. 64003-52-7. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lacto-N-neooctaose | Lacto-N-neooctaose is a biomedical product, emerging as a prebiotic and fomenting substantial research in gut health. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-Glc; LNnO. Molecular formula: C54H91N3O41. Mole weight: 1438.30. | |
| Lacto-N-neotetraosa-APD-HSA | | |
| Lacto-N-neotetraose | Lacto-N-neotetraose is a valuable biomolecule predominantly utilized as a prebiotic supplement. Additionally, Lacto-N-neotetraose has shown potential in modulating the immune system, making it a promising candidate for the research of various autoimmune disorders. Synonyms: Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNnT; O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-D-Glucose; N-Neotetraose; beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc; beta-D-galactosyl-(1->4)-beta-D-N-acetylglucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose. Grades: ≥95%. CAS No. 13007-32-4. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Lacto-N-neotetraose | Lacto-N-neotetraose (LNnT) is an endogenous metabolite. Lacto-N-neotetraose can inhibit TNF-α induced IL-8 secretion in immature epithelial cells. Lacto-N-neotetraose has anti-inflammatory avtivity, and can improve the wound closure [1] [2] [4]. Uses: Scientific research. Group: Natural products. Alternative Names: LNnT. CAS No. 13007-32-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N9445. | |
| Lacto-N-neo-tetraose | synthetic, ?85% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| Lacto-N-neotetraose-GEL | | |
| Lacto-N-tetraose | Lacto-N-tetraose is a fascinating carbohydrate compound, aiding in studying gastrointestinal disorders and specific cancer variants. Synonyms: Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; LNT; R-lactotetraose-HSA; Beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose; BetaD-Galp(1?3)betaD-GlcpNAc(1?3)betaD-Galp(1?4)D-Glcp; 4-O-[3-O-[3-O-beta-D-Galactopyranosyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-beta-D-galactopyranosyl]-D-glucopyranose. Grades: ≥90%. CAS No. 14116-68-8. Molecular formula: C26H45NO21. Mole weight: 707.63. | |
| Lacto-N-tetraose | Lacto-N-tetraose is the significant core structure of human milk oligosaccharides (HMOs) naturally existing in human milk. Lacto-N-tetraose is consist of galactose, N-acetylglucosamine, and glucose moieties. Lacto-N-tetraose has prebiotic effect, immune regulatory effect, anti-inflammatory effects, intestinal cell responses regulatory effect, antibacterial activity and antiviral activity. Lacto-N-tetraose has been widely added to infant formula [1]. Uses: Scientific research. Group: Natural products. CAS No. 14116-68-8. Pack Sizes: 5 mg; 10 mg. Product ID: HY-N9448. | |
| Lacto-N-tetraose-a-APD-HSA | | |
| Lacto-N-tetraose-APD-KLH | Lacto-N-tetraose-APD-KLH is a fascinating biomedical compound, exhibiting profound immunostimulatory properties. This remarkable compound works tirelessly to instigate the generation of bespoke antibodies, specifically tailored to study recalcitrant pathogens or malignancies. | |
| Lacto-N-tetraose-BSA | | |
| Lacto-N-tetraose-GEL | Lacto-N-tetraose-GEL is a remarkable biomedical compound, unleashing its formidable antibacterial prowess. This unique gel formulation graciously diffuses its potency to effectively thwart Gram-positive and Gram-negative strains alike. | |
| Lacto-N-tetraose LNT | Galb1®3GlcNAcb1®3Galb1®3Glc core structure. Lewisx tumor-associated trisaccharide antigen, E- and P-selectin ligand, anti-inflammatory agent. CAS No. 14116-68-8. Product ID: 3-00426. Molecular formula: C26H45NO21. Mole weight: 707.64. Reference: Science, 260, 906, 1993; J. Exp. Med., 178, 623, 1993. | |
| Lacto-N-triose I | Lacto-N-triose I is an avant-garde compound, exhibiting significant potency in impeding bacterial adhesion. It can aid in studying infections instigated by uropathogenic Escherichia coli. Synonyms: O-b-D-Galactopyranosyl-(1?3)-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1?4)-D-galactose. CAS No. 19945-86-9. Molecular formula: C20H35NO16. Mole weight: 545.49. | |
| Lacto-N-triose II | Lacto-N-triose II is a profoundly sophisticated compound, vividly contributing to studying an assortment of afflictions, notably cancer, autoimmune disorders and neurological ailments. It has the unparalleled aptitude for pinpointing discrete cells and catalyzing targeted pharmaceutical transportation. Synonyms: D-Glucose, O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-; O-2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-D-glucose; Lacto-N-triaose; Agalacto-N-neotetraose. CAS No. 75645-27-1. Molecular formula: C20H35NO16. Mole weight: 545.49. | |
| Lactoperoxidase | Lactoperoxidase. CAS No. 9003-99-0. Product ID: 2-08240. | |
| Lactophenol | Lactophenol. Uses: Designed for use in research and industrial production. Additional or Alternative Names: LactophenolForMicroscopy. Product Category: Heterocyclic Organic Compound. CAS No. 55068-66-1. Density: 1.11-1.21. Product ID: ACM55068661. Alfa Chemistry ISO 9001:2015 Certified. Categories: Lactophenol cotton blue. | |
| Lactoquinomycin A | It is produced by the strain of Str. tanashiensis IM 8442T. It's a quinone antibiotic. It has the activity of anti-gram-positive bacteria and some gram-negative bacteria, but the effect of anti-gram-negative bacteria is weak and has no effect on fungi. Lactoquinomycin A has stronger antibacterial activity than Lactoquinomycin B. It inhibits a variety of cell lines including lymphoma L5178Y progenitor, adriamycin resistant, bleomycin-resistant, human leukemia K562, mouse leukemia L-1210 and mouse leukemia P 388 with ID50 (μg/mL) of 0.02, 0.006, 0.008, 0.033, 0.013 and 0.03, respectively. Synonyms: Lactoquinomycin A; Medermycin; [3aS,(-)]-3,3aβ,5,11bβ-Tetrahydro-7-hydroxy-5β-methyl-8-[3-(dimethylamino)-2,3,6-trideoxy-L-arabino-hexopyranosyl]-2H-furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione; Antibiotic K 73A; 2H-Furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione,3,3a,5,11b-tetrahydro-7-hydroxy-5-methyl-8-[2,3,6-trideoxy-3-(dimethylamino)-beta-D-arabino-hexopyranosyl]-, (3aR,5R,11bR)-. Grades: 95%. CAS No. 60227-09-0. Molecular formula: C24H27NO8. Mole weight: 457.48. | |
| Lactoquinomycin B | It is produced by the strain of Str. tanashiensis IM 8442T. It's a quinone antibiotic. It has the activity of anti-gram-positive bacteria and some gram-negative bacteria, but the effect of anti-gram-negative bacteria is weak and has no effect on fungi. Lactoquinomycin A has stronger antibacterial activity than Lactoquinomycin B. It inhibits a variety of cell lines including lymphoma L5178Y progenitor, adriamycin resistant, bleomycin-resistant, human leukemia K562, mouse leukemia L-1210 and mouse leukemia P 388 with ID50 (μg/mL) of 0.43, 0.21, 0.19, 0.16, 0.2 and 0.12, respectively. Synonyms: 3a,11b-Dihydro-7-hydroxy-5-methyl-8-[2,3,6-trideoxy-3-(dimethylamino)-β-D-arabino-hexopyranosyl]-5a,11a-epoxy-5H-furo[3,2-b]naphtho[2,3-d]pyran-2,6,11(3H)-trione; 5a,11a-Epoxy-5H-furo[3,2-b]naphtho[2,3-d]pyran-2,6,11(3H)-trione, 3a,11b-dihydro-7-hydroxy-5-methyl-8-[2,3,6-trideoxy-3-(dimethylamino)-b-D-arabino-hexopyranosyl]-. CAS No. 101342-94-3. Molecular formula: C24H27NO9. Mole weight: 473.48. | |
| Lactosamine | Lactosamine forms the backbone of several cell surface glycans such as sialylated glycans or keratin sulfates. Also, it is a basic structural element of Lewis type, and human milk oligosaccharides. Group: Biochemicals. Grades: Highly Purified. CAS No. 13000-25-4. Pack Sizes: 5mg, 10mg. Molecular Formula: C12H23NO10, Molecular Weight: 341.31. US Biological Life Sciences. |  Worldwide |
| Lactosazone | Lactosazone is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct. Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose. Synonyms: 4-O-β-D-Galactopyranosyl-D-arabino-hexosulose Bis(phenylhydrazone); Lactose Phenylosazone; NSC 56106; 4-O-β-D-Galactopyranosyl-D-arabino-Hexos-2-ulose Bis(phenylhydrazone). Grades: 97%. CAS No. 4746-17-2. Molecular formula: C24H32N4O9. Mole weight: 520.53. | |
| Lactoscatone | Lactoscatone. CAS No. 21280-29-5. VIGON Item # 502515. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers. |  America & Internationally |
| Lactose | Lactose is a β-galactoside consisting of galactose and glucose residues, the main carbohydrate in mammalian breast milk. Lactose, a macronutrient and an inducer of host innate immune responses, possesses immune modulatory functions [1] [2] [3]. Uses: Scientific research. Group: Natural products. CAS No. 63-42-3. Pack Sizes: 10 mM * 1 mL; 500 mg; 1 g. Product ID: HY-B2123. | |
| Lactose | Lactose. CAS No. 63-42-3. Product ID: PE-0232. Molecular formula: C12H22O11. Mole weight: 342.296. Category: Diluent Excipients. Product Keywords: Pharmaceutical Excipients; Solid Dosage Form; Filler Excipients; Diluent Excipients; Lactose; PE-0232; C12H22O11; 63-42-3; 63-42-3. Appearance: White crystals or powder. Purity: 0.99. Boiling Point: 667.9°C at 760 mmHg. Melting Point: 201-202°C. Density: 1.76 g/cm3. | |
| Lactose | Lactose. CAS No. 63-42-3. Product ID: PE-0007. Molecular formula: C12H22O11. Mole weight: 342.296. Category: Carrier Excipients; Corrective Excipients. Product Keywords: Pharmaceutical Excipients; Excipients for Liquid Dosage Form; Corrective Excipients; Lactose; PE-0007; C12H22O11; 63-42-3; 63-42-3. Appearance: White crystals or powder. Purity: 0.99. Boiling Point: 667.9°C at 760 mmHg. Melting Point: 201-202°C. Density: 1.76 g/cm3. | |
| Lactose | 100g Pack Size. Group: Analytical Reagents, Biochemicals, Building Blocks, Carbohydrates. Formula: C12H22O11. CAS No. 14641-93-1. Prepack ID 89982198-100g. Molecular Weight 342.3. See USA prepack pricing. |  |
| Lactose | 4-O-b-D-galactopyranosyl-D-glucose. sweetener. CAS No. 5989-81-1. Product ID: 3-00064. Molecular formula: C12H22O11. Mole weight: 342.34. Properties: powder. Source : | |
| Lactose 1-O-allyl | Lactose 1-O-allyl is a crucial compound playing a vital role in drug development by serving as a versatile building block for the synthesis of various pharmaceutical compounds. Its derivatives have shown potential in studying certain diseases such as diabetes, liver disorders and inflammation. Molecular formula: C15H26O11. Mole weight: 382.36. | |
| Lactose 3-sulfate | Lactose 3-sulfate is an esteemed compound of immense worth employed, astoundingly showcases profound efficacy in studying a myriad of afflictions, including cancer and inflammation. Synonyms: 4-O-(3-O-Sulfo-b-D-galactopyranosyl)-D-glucopyranose. CAS No. 159358-51-7. Molecular formula: C12H22O14S. Mole weight: 422.36. | |
| Lactose 6-sulfate | Lactose 6-sulfate is a notable disaccharide possessing a sulfate moiety, extensively employed in the realm of biomedical investigation. Significantly, it exhibits exceptional immunogenicity, qualifying as an invaluable probe for examining intricate carbohydrate-protein alliances and glycosaminoglycan biogenesis. Synonyms: Lactose 6'-sulfate; 1015758-24-3. CAS No. 1015758-24-3. Molecular formula: C12H22O14S. Mole weight: 422.36. | |
| Lactose anhydrous | 4-O-b-D-galactopyranosyl-D-glucose. Grades: NF. CAS No. 63-42-3. Product ID: 8-01336. Molecular formula: C12H22O11. Mole weight: 342.34. Properties: 0-3 Pas. | |
| Lactose - anhydrous | Lactose - anhydrous. Uses: Designed for use in research and industrial production. CAS No. 63-42-3. Purity: 0.98. Product ID: ACM63423-4. Alfa Chemistry ISO 9001:2015 Certified. | |
| Lactose - anhydrous | Cas No. 63-42-3. | |
| Lactose (anhydrous) | European Pharmacopoeia (Ph. Eur.); Pharmacopoeial Standards. Uses: For analytical and research use. Group: Reagents. Alternative Names: Galactinum, Lactose anhydride, Prismalac, PrenoLakt, Pharmatosa DCL 21, Nonpareil 107, Fast-flo, LE-PRO LAC 451, Flowlac 100, Lactose DCL 11, Lactose (8CI), Respitose SV 010, Tablettose 80, Lactin, Variolac 960, Zeparox EP, Tablettose 70, Osmolactan, Lactose Fast-flo, Milk sugar, Respitose ML 001, Lactose anhydrous, Saccharum lactin, DCL 15, Super-Tab, Granulac 140, Pharmatose 325M, Lactin (carbohydrate), Sorbalac 400, Spherolac, D-(+)-Lactose, Fast-Flo Lactose, Pharmatose 21, (+)-Lactose, Pharmatose DCL 15, Lactohale 300, Respitose ML 003, Sachelac, DCl 11, Granulac 70, Lactohale 200, O-?-d-Galactopyranosyl-(1?4)-?-d-glucopyranose, Sorbolac 400, Respitose MC 001, Respitose SV 003, Tablettose, D-Glucose, 4-O-?-D-galactopyranosyl-, SuperTab 21AN, Granulac 140M, Lactose Edible 90, Inhalac 70,Lactose, AHL, Dilactose, Lactobiose, SuperTab 11SD, Respitose ML 006, Dairylac 80, Inhalac 250, Lactohale 100, Aletobiose. CAS No. 63-42-3. IUPAC Name: (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6RS)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol. | |
| Lactose, Anhydrous | Sweetener Standards. Uses: For analytical and research use. Group: Reagents. Grades: certified reference material; pharmaceutical secondary standard. CAS No. 63-42-3. Pack Sizes: 1G. | |
| Lactose, Anhydrous | Pharmaceutical Secondary Standard; Certified Reference Material. Group: Sweetener standards. | |
Our database is helping our users find suppliers everyday.
